Skip to content

Varenne Capital Partners: TSM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Varenne Capital Partners on TSM, newest first. How the timeline and the estimate are built.

Varenne Capital Partners held 153,341 TSM shares at 2026-06-30 per its 13F-HR filed 2026-08-10.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 153,341 shares
    Change vs previous 13F -31,266 shares

    12.28% of the 13F portfolio, value $73,179,806.

    13F-HR 0000945621-26-000997 filed by Varenne Capital Partners
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 184,607 shares
    Change vs previous 13F +1,862 shares

    15.53% of the 13F portfolio, value $62,582,948.

    13F-HR 0000945621-26-000681 filed by Varenne Capital Partners
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 182,745 shares
    Change vs previous 13F +182,745 shares

    11.56% of the 13F portfolio, value $55,559,487.

    13F-HR 0000945621-26-000325 filed by Varenne Capital Partners
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -132,480 shares

    13F-HR 0000945621-25-001070 filed by Varenne Capital Partners
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2025-06-30
    13F 132,480 shares
    Change vs previous 13F not available

    7.57% of the 13F portfolio, value $30,005,395.

    13F-HR 0000945621-25-000733 filed by Varenne Capital Partners
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).